Hims & Hers Health, INC Form 4 insider transactions

CEO Andrew Dudum exercised stock options and sold shares of Hims & Hers Health, Inc. on April 16, 2025, according to a Form 4 filing with the SEC.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reported selling shares of Class A Common Stock on March 3, 2025, and April 14, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CFO Oluyemi Okupe exercised stock options and sold shares of Class A Common Stock on April 15, 2025, under a pre-arranged 10b5-1 trading plan.

Chief Operating Officer of Hims & Hers Health, Melissa Baird, exercised stock options and sold shares of Class A Common Stock on April 9, 2025, according to a Form 4 filing with the SEC.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc., reports exercising stock options and acquiring Class A Common Stock on April 4, 2025.

Irene Becklund, PAO of Hims & Hers Health, Inc., reports selling 2,203 shares of Class A Common Stock on April 3, 2025, at a price of $28.78 per share.

Hims & Hers Health CFO Oluyemi Okupe exercised stock options and sold shares of Class A Common Stock on April 2, 2025, according to a Form 4 filing with the SEC.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, exercised stock options on March 31, 2025, acquiring 13,460 shares of Class A Common Stock.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 3,236 shares of Class A Common Stock at a price of $27.77 per share on March 31, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health's Chief Operating Officer, Melissa Baird, exercised stock options and sold shares of Class A Common Stock on March 26, 2025, according to a Form 4 filing with the SEC.

Oluyemi Okupe, CFO of Hims & Hers Health, Inc., sold 23,118 shares of Class A Common Stock at an average price of $32.4066 on March 21, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Director and Chief Medical Officer Patrick Harrison Carroll reports acquisition and disposal of Hims & Hers Health, Inc. Class A Common Stock and Restricted Stock Units.

Hims & Hers Health CEO Andrew Dudum exercised stock options and sold shares of Class A Common Stock on March 14 and March 17-18, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Chief Financial Officer Oluyemi Okupe of Hims & Hers Health, Inc. reports the vesting and disposal of restricted stock units to cover tax obligations.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.

Director Christiane Pendarvis reports acquisition of Hims & Hers Health Class A Common Stock through vesting of Restricted Stock Units.

Irene Becklund, PAO of Hims & Hers Health, reports the vesting and sale of Class A Common Stock and Restricted Stock Units.

Chief Commercial Officer Michael Chi reports the vesting and settlement of Restricted Stock Units (RSUs) and associated tax withholding, resulting in changes to his beneficial ownership of Hims & Hers Health, Inc. stock.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc., reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units on March 14, 2025.

CEO Andrew Dudum reports the acquisition of 306,406 Restricted Stock Units (RSUs) in Hims & Hers Health, Inc. on March 11, 2025, according to a Form 4 filing.

Irene Becklund, PAO of Hims & Hers Health, reports the sale of 2,203 shares of Class A Common Stock and the acquisition of 22,284 Restricted Stock Units.

Director Christiane Pendarvis sold 12,500 shares of Hims & Hers Health, Inc. Class A Common Stock at $40 per share on March 5, 2025.

Chief Financial Officer Oluyemi Okupe of Hims & Hers Health, Inc. exercised stock options to acquire 2,530 shares of Class A Common Stock at $5.01 per share on March 5, 2025.

Irene Becklund, PAO of Hims & Hers Health, sold 2,913 shares of Class A Common Stock at $45.14 per share on March 3, 2025, under a pre-arranged 10b5-1 trading plan.

Patrick Harrison Carroll, Chief Medical Officer and Director at Hims & Hers Health, Inc., acquired 56,529 Restricted Stock Units (RSUs) on March 3, 2025, which will vest over a four-year period.

Chief Financial Officer of Hims & Hers Health, Oluyemi Okupe, reports the acquisition of 183,719 Restricted Stock Units (RSUs) tied to Class A Common Stock, vesting quarterly over four years.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc., acquired 197,851 restricted stock units (RSUs) on March 3, 2025, which will vest over a four-year period.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., acquired 169,587 Restricted Stock Units (RSUs) on March 3, 2025, which will vest over a four-year period.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., was granted 98,925 Restricted Stock Units (RSUs) on March 3, 2025, according to a Form 4 filing with the SEC.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.